Global Active Transdermal Drug Delivery Device Market Insights, Forecast to 2025

Choose Licence

 

The global Active Transdermal Drug Delivery Device market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025. The objectives of this study are to define, segment, and project the size of the Active Transdermal Drug Delivery Device market based on company, product type, end user and key regions. This report studies the global market size of Active Transdermal Drug Delivery Device in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Active Transdermal Drug Delivery Device in these regions. This research report categorizes the global Active Transdermal Drug Delivery Device market by top players/brands, region, type and end user. This report also studies the global Active Transdermal Drug Delivery Device market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors. The following manufacturers are covered in this report, with sales, revenue, market share for each company: Novartis AG Noven Pharmaceuticals, Inc. Transdermal Corp. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Mylan N.V. 3M Actavis, Inc. Bayer AG Boehringer Ingelheim GmbH Corium International, Inc. Echo Therapeutics, Inc. GlaxoSmithKline plc Market size by Product Patches Gels Market size by End User Clinic Hospital Home Use Market size by Region North America United States Canada Mexico Asia-Pacific China India Japan South Korea Australia Indonesia Singapore Malaysia Philippines Thailand Vietnam Europe Germany France UK Italy Spain Russia Central & South America Brazil Rest of Central & South America Middle East & Africa GCC Countries Turkey Egypt South Africa The study objectives of this report are: To study and analyze the global Active Transdermal Drug Delivery Device market size (value & volume) by company, key regions, products and end user, breakdown data from 2013 to 2017, and forecast to 2025. To understand the structure of Active Transdermal Drug Delivery Device market by identifying its various subsegments. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). Focuses on the key global Active Transdermal Drug Delivery Device companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development. To project the value and sales volume of Active Transdermal Drug Delivery Device submarkets, with respect to key regions. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. In this study, the years considered to estimate the market size of Active Transdermal Drug Delivery Device are as follows: History Year: 2013-2017 Base Year: 2017 Estimated Year: 2018 Forecast Year 2018 to 2025 This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Active Transdermal Drug Delivery Device market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources. For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

 

Table of Contents 1 Study Coverage 1.1 Active Transdermal Drug Delivery Device Product 1.2 Market Segments 1.3 Key Manufacturers Covered 1.4 Market by Type 1.4.1 Global Active Transdermal Drug Delivery Device Market Size Growth Rate by Product 1.4.2 Patches 1.4.3 Gels 1.5 Market by End User 1.5.1 Global Active Transdermal Drug Delivery Device Market Size Growth Rate by End User 1.5.2 Clinic 1.5.3 Hospital 1.5.4 Home Use 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Active Transdermal Drug Delivery Device Market Size 2.1.1 Global Active Transdermal Drug Delivery Device Revenue 2013-2025 2.1.2 Global Active Transdermal Drug Delivery Device Sales 2013-2025 2.2 Active Transdermal Drug Delivery Device Growth Rate by Regions 2.2.1 Global Active Transdermal Drug Delivery Device Sales by Regions 2.2.2 Global Active Transdermal Drug Delivery Device Revenue by Regions 3 Breakdown Data by Manufacturers 3.1 Active Transdermal Drug Delivery Device Sales by Manufacturers 3.1.1 Active Transdermal Drug Delivery Device Sales by Manufacturers 3.1.2 Active Transdermal Drug Delivery Device Sales Market Share by Manufacturers 3.1.3 Global Active Transdermal Drug Delivery Device Market Concentration Ratio (CR5 and HHI) 3.2 Active Transdermal Drug Delivery Device Revenue by Manufacturers 3.2.1 Active Transdermal Drug Delivery Device Revenue by Manufacturers (2013-2018) 3.2.2 Active Transdermal Drug Delivery Device Revenue Share by Manufacturers (2013-2018) 3.3 Active Transdermal Drug Delivery Device Price by Manufacturers 3.4 Active Transdermal Drug Delivery Device Manufacturing Base Distribution, Product Types 3.4.1 Active Transdermal Drug Delivery Device Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Active Transdermal Drug Delivery Device Product Type 3.4.3 Date of International Manufacturers Enter into Active Transdermal Drug Delivery Device Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Product 4.1 Global Active Transdermal Drug Delivery Device Sales by Product 4.2 Global Active Transdermal Drug Delivery Device Revenue by Product 4.3 Active Transdermal Drug Delivery Device Price by Product 5 Breakdown Data by End User 5.1 Overview 5.2 Global Active Transdermal Drug Delivery Device Breakdown Data by End User 6 North America 6.1 North America Active Transdermal Drug Delivery Device by Countries 6.1.1 North America Active Transdermal Drug Delivery Device Sales by Countries 6.1.2 North America Active Transdermal Drug Delivery Device Revenue by Countries 6.1.3 United States 6.1.4 Canada 6.1.5 Mexico 6.2 North America Active Transdermal Drug Delivery Device by Product 6.3 North America Active Transdermal Drug Delivery Device by End User 7 Europe 7.1 Europe Active Transdermal Drug Delivery Device by Countries 7.1.1 Europe Active Transdermal Drug Delivery Device Sales by Countries 7.1.2 Europe Active Transdermal Drug Delivery Device Revenue by Countries 7.1.3 Germany 7.1.4 France 7.1.5 UK 7.1.6 Italy 7.1.7 Russia 7.2 Europe Active Transdermal Drug Delivery Device by Product 7.3 Europe Active Transdermal Drug Delivery Device by End User 8 Asia Pacific 8.1 Asia Pacific Active Transdermal Drug Delivery Device by Countries 8.1.1 Asia Pacific Active Transdermal Drug Delivery Device Sales by Countries 8.1.2 Asia Pacific Active Transdermal Drug Delivery Device Revenue by Countries 8.1.3 China 8.1.4 Japan 8.1.5 Korea 8.1.6 India 8.1.7 Australia 8.1.8 Indonesia 8.1.9 Malaysia 8.1.10 Philippines 8.1.11 Thailand 8.1.12 Vietnam 8.1.13 Singapore 8.2 Asia Pacific Active Transdermal Drug Delivery Device by Product 8.3 Asia Pacific Active Transdermal Drug Delivery Device by End User 9 Central & South America 9.1 Central & South America Active Transdermal Drug Delivery Device by Countries 9.1.1 Central & South America Active Transdermal Drug Delivery Device Sales by Countries 9.1.2 Central & South America Active Transdermal Drug Delivery Device Revenue by Countries 9.1.3 Brazil 9.2 Central & South America Active Transdermal Drug Delivery Device by Product 9.3 Central & South America Active Transdermal Drug Delivery Device by End User 10 Middle East and Africa 10.1 Middle East and Africa Active Transdermal Drug Delivery Device by Countries 10.1.1 Middle East and Africa Active Transdermal Drug Delivery Device Sales by Countries 10.1.2 Middle East and Africa Active Transdermal Drug Delivery Device Revenue by Countries 10.1.3 GCC Countries 10.1.4 Turkey 10.1.5 Egypt 10.1.6 South Africa 10.2 Middle East and Africa Active Transdermal Drug Delivery Device by Product 10.3 Middle East and Africa Active Transdermal Drug Delivery Device by End User 11 Company Profiles 11.1 Novartis AG 11.1.1 Novartis AG Company Details 11.1.2 Company Business Overview 11.1.3 Novartis AG Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2013-2018) 11.1.4 Novartis AG Active Transdermal Drug Delivery Device Products Offered 11.1.5 Novartis AG Recent Development 11.2 Noven Pharmaceuticals, Inc. 11.2.1 Noven Pharmaceuticals, Inc. Company Details 11.2.2 Company Business Overview 11.2.3 Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2013-2018) 11.2.4 Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Products Offered 11.2.5 Noven Pharmaceuticals, Inc. Recent Development 11.3 Transdermal Corp. 11.3.1 Transdermal Corp. Company Details 11.3.2 Company Business Overview 11.3.Transdermal Corp. Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2013-2018) 11.3.4 Transdermal Corp. Active Transdermal Drug Delivery Device Products Offered 11.3.5 Transdermal Corp. Recent Development 11.4 Johnson & Johnson (Janssen Pharmaceuticals Inc.) 11.4.1 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Company Details 11.4.2 Company Business Overview 11.4.3 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2013-2018) 11.4.4 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Products Offered 11.4.5 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Recent Development 11.5 Mylan N.V. 11.5.1 Mylan N.V. Company Details 11.5.2 Company Business Overview 11.5.3 Mylan N.V. Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2013-2018) 11.5.4 Mylan N.V. Active Transdermal Drug Delivery Device Products Offered 11.5.5 Mylan N.V. Recent Development 11.6 3M 11.6.1 3M Company Details 11.6.2 Company Business Overview 11.6.3 3M Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2013-2018) 11.6.4 3M Active Transdermal Drug Delivery Device Products Offered 11.6.5 3M Recent Development 11.7 Actavis, Inc. 11.7.1 Actavis, Inc. Company Details 11.7.2 Company Business Overview 11.7.3 Actavis, Inc. Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2013-2018) 11.7.4 Actavis, Inc. Active Transdermal Drug Delivery Device Products Offered 11.7.5 Actavis, Inc. Recent Development 11.8 Bayer AG 11.8.1 Bayer AG Company Details 11.8.2 Company Business Overview 11.8.3 Bayer AG Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2013-2018) 11.8.4 Bayer AG Active Transdermal Drug Delivery Device Products Offered 11.8.5 Bayer AG Recent Development 11.9 Boehringer Ingelheim GmbH 11.9.1 Boehringer Ingelheim GmbH Company Details 11.9.2 Company Business Overview 11.9.3 Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2013-2018) 11.9.4 Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Products Offered 11.9.5 Boehringer Ingelheim GmbH Recent Development 11.10 Corium International, Inc. 11.10.1 Corium International, Inc. Company Details 11.10.2 Company Business Overview 11.10.3 Corium International, Inc. Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2013-2018) 11.10.4 Corium International, Inc. Active Transdermal Drug Delivery Device Products Offered 11.10.5 Corium International, Inc. Recent Development 11.11 Echo Therapeutics, Inc. 11.12 GlaxoSmithKline plc 12 Future Forecast 12.1 Active Transdermal Drug Delivery Device Market Forecast by Regions 12.1.1 Global Active Transdermal Drug Delivery Device Sales Forecast by Regions 2018-2025 12.1.2 Global Active Transdermal Drug Delivery Device Revenue Forecast by Regions 2018-2025 12.2 Active Transdermal Drug Delivery Device Market Forecast by Product 12.2.1 Global Active Transdermal Drug Delivery Device Sales Forecast by Product 2018-2025 12.2.2 Global Active Transdermal Drug Delivery Device Revenue Forecast by Product 2018-2025 12.3 Active Transdermal Drug Delivery Device Market Forecast by End User 12.4 North America Active Transdermal Drug Delivery Device Forecast 12.5 Europe Active Transdermal Drug Delivery Device Forecast 12.6 Asia Pacific Active Transdermal Drug Delivery Device Forecast 12.7 Central & South America Active Transdermal Drug Delivery Device Forecast 12.8 Middle East and Africa Active Transdermal Drug Delivery Device Forecast 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Macroscopic Indicators 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Active Transdermal Drug Delivery Device Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables and Figures Figure Active Transdermal Drug Delivery Device Product Picture Table Active Transdermal Drug Delivery Device Market Segments Table Key Manufacturers Active Transdermal Drug Delivery Device Covered Table Global Active Transdermal Drug Delivery Device Market Size Growth Rate by Product 2018-2025 (K Units) & (Million US$) Figure Global Active Transdermal Drug Delivery Device Sales Market Share by Product 2013-2025 Figure Patches Product Picture Table Major Manufacturers of Patches Figure Gels Product Picture Table Major Manufacturers of Gels Table Global Active Transdermal Drug Delivery Device Market Size Growth Rate by End User 2018-2025 (K Units) Figure Clinic Figure Hospital Figure Home Use Figure Active Transdermal Drug Delivery Device Report Years Considered Figure Global Active Transdermal Drug Delivery Device Market Size 2013-2025 (Million US$) Figure Global Active Transdermal Drug Delivery Device Sales 2013-2025 (K Units) Table Global Active Transdermal Drug Delivery Device Market Size by Regions 2013-2018 (K Units) & (Million US$) Table Global Active Transdermal Drug Delivery Device Sales by Regions 2013-2018 (K Units) Table Global Active Transdermal Drug Delivery Device Sales Market Share by Regions 2013-2018 Figure Global Active Transdermal Drug Delivery Device Sales Market Share by Regions 2013-2018 Figure 2017 Global Active Transdermal Drug Delivery Device Sales Market Share by Regions Table Global Active Transdermal Drug Delivery Device Revenue by Regions 2013-2018 (Million US$) Table Global Active Transdermal Drug Delivery Device Revenue Market Share by Regions 2013-2018 Figure Global Active Transdermal Drug Delivery Device Revenue Market Share by Regions 2013-2018 Figure 2017 Global Active Transdermal Drug Delivery Device Revenue Market Share by Regions Table Global Active Transdermal Drug Delivery Device Sales by Manufacturers (2013-2018) (K Units) Table Global Active Transdermal Drug Delivery Device Sales Share by Manufacturers (2013-2018) Figure Global Active Transdermal Drug Delivery Device Sales Share by Manufacturers in 2017 Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Active Transdermal Drug Delivery Device Revenue by Manufacturers (2013-2018) (Million USD) Table Active Transdermal Drug Delivery Device Revenue Share by Manufacturers (2013-2018) Figure Active Transdermal Drug Delivery Device Value Share by Manufacturers in 2017 Table Key Manufacturers Active Transdermal Drug Delivery Device Price (2013-2018) (USD/Unit) Table Active Transdermal Drug Delivery Device Manufacturers Manufacturing Base Distribution and Headquarters Table Manufacturers Active Transdermal Drug Delivery Device Product Type Table Date of International Manufacturers Enter into Active Transdermal Drug Delivery Device Market Table Manufacturers Mergers & Acquisitions, Expansion Plans Table Global Active Transdermal Drug Delivery Device Sales by Product (2013-2018) (K Units) Table Global Active Transdermal Drug Delivery Device Sales Share by Product (2013-2018) Figure Global Active Transdermal Drug Delivery Device Sales Market Share by Product (2013-2018) Figure Global Active Transdermal Drug Delivery Device Sales Market Share by Product in 2017 Table Global Active Transdermal Drug Delivery Device Revenue by Product (2013-2018) (Million US$) Table Global Active Transdermal Drug Delivery Device Revenue Share by Product (2013-2018) Figure Global Active Transdermal Drug Delivery Device Revenue Market Share by Product (2013-2018) Figure Global Active Transdermal Drug Delivery Device Revenue Market Share by Product in 2017 Table Active Transdermal Drug Delivery Device Price by Product 2013-2018 (USD/Unit) Table Global Active Transdermal Drug Delivery Device Sales by End User (2013-2018) (K Units) Table Global Active Transdermal Drug Delivery Device Sales Share by End User (2013-2018) Figure Global Sales Active Transdermal Drug Delivery Device Market Share by End User (2013-2018) Figure Global Sales Active Transdermal Drug Delivery Device Market Share by End User in 2017 Figure North America Active Transdermal Drug Delivery Device Sales Growth Rate 2013-2018 (K Units) Figure North America Active Transdermal Drug Delivery Device Revenue Growth Rate 2013-2018 (Million US$) Table North America Active Transdermal Drug Delivery Device Sales by Countries (2013-2018) (K Units) Table North America Active Transdermal Drug Delivery Device Sales Market Share by Countries (2013-2018) Figure 2017 North America Active Transdermal Drug Delivery Device Sales Market Share by Countries Table North America Active Transdermal Drug Delivery Device Revenue by Countries (2013-2018) (Million US$) Table North America Active Transdermal Drug Delivery Device Revenue Market Share by Countries (2013-2018) Figure 2017 North America Active Transdermal Drug Delivery Device Revenue Market Share by Countries Figure United States Active Transdermal Drug Delivery Device Sales Growth Rate (2013-2018) (K Units) Figure United States Active Transdermal Drug Delivery Device Revenue Growth Rate (2013-2018) (K Units) Figure Canada Active Transdermal Drug Delivery Device Sales Growth Rate (2013-2018) (K Units) Figure Canada Active Transdermal Drug Delivery Device Revenue Growth Rate (2013-2018) (Million US$) Figure Mexico Active Transdermal Drug Delivery Device Sales Growth Rate (2013-2018) (K Units) Figure Mexico Active Transdermal Drug Delivery Device Revenue Growth Rate (2013-2018) (Million US$) Table North America Active Transdermal Drug Delivery Device Sales by Product (2013-2018) (K Units) Table North America Active Transdermal Drug Delivery Device Sales Market Share by Product (2013-2018) Figure 2017 North America Active Transdermal Drug Delivery Device Market Share by Product Table North America Active Transdermal Drug Delivery Device Sales by End User (2013-2018) (K Units) Table North America Active Transdermal Drug Delivery Device Sales Market Share by End User (2013-2018) Figure 2017 North America Active Transdermal Drug Delivery Device Market Share by End User Figure Europe Active Transdermal Drug Delivery Device Sales Growth Rate 2013-2018 (K Units) Figure Europe Active Transdermal Drug Delivery Device Revenue Growth Rate 2013-2018 (Million US$) Table Europe Active Transdermal Drug Delivery Device Sales by Countries (2013-2018) (K Units) Table Europe Active Transdermal Drug Delivery Device Sales Market Share by Countries (2013-2018) Figure 2017 Europe Active Transdermal Drug Delivery Device Sales Market Share by Countries Table Europe Active Transdermal Drug Delivery Device Revenue by Countries (2013-2018) (Million US$) Table Europe Active Transdermal Drug Delivery Device Revenue Market Share by Countries (2013-2018) Figure 2017 Europe Active Transdermal Drug Delivery Device Revenue Market Share by Countries Figure Germany Active Transdermal Drug Delivery Device Sales Growth Rate (2013-2018) (K Units) Figure Germany Active Transdermal Drug Delivery Device Revenue Growth Rate (2013-2018) (Million US$) Figure France Active Transdermal Drug Delivery Device Sales Growth Rate (2013-2018) (K Units) Figure France Active Transdermal Drug Delivery Device Revenue Growth Rate (2013-2018) (Million US$) Figure UK Active Transdermal Drug Delivery Device Sales Growth Rate (2013-2018) (K Units) Figure UK Active Transdermal Drug Delivery Device Revenue Growth Rate (2013-2018) (Million US$) Figure Italy Active Transdermal Drug Delivery Device Sales Growth Rate (2013-2018) (K Units) Figure Italy Active Transdermal Drug Delivery Device Revenue Growth Rate (2013-2018) (Million US$) Figure Russia Active Transdermal Drug Delivery Device Sales Growth Rate (2013-2018) (K Units) Figure Russia Active Transdermal Drug Delivery Device Revenue Growth Rate (2013-2018) (Million US$) Table Europe Active Transdermal Drug Delivery Device Sales by Product (2013-2018) (K Units) Table Europe Active Transdermal Drug Delivery Device Sales Market Share by Product (2013-2018) Figure 2017 Europe Active Transdermal Drug Delivery Device Market Share by Product Table Europe Active Transdermal Drug Delivery Device Sales by End User (2013-2018) (K Units) Table Europe Active Transdermal Drug Delivery Device Sales Market Share by End User (2013-2018) Figure 2017 Europe Active Transdermal Drug Delivery Device Market Share by End User Figure Asia Pacific Active Transdermal Drug Delivery Device Sales Growth Rate 2013-2018 (K Units) Figure Asia Pacific Active Transdermal Drug Delivery Device Revenue Growth Rate 2013-2018 (Million US$) Table Asia Pacific Active Transdermal Drug Delivery Device Sales by Countries (2013-2018) (K Units) Table Asia Pacific Active Transdermal Drug Delivery Device Sales Market Share by Countries (2013-2018) Figure 2017 Asia Pacific Active Transdermal Drug Delivery Device Sales Market Share by Countries Table Asia Pacific Active Transdermal Drug Delivery Device Revenue by Countries (2013-2018) (Million US$) Table Asia Pacific Active Transdermal Drug Delivery Device Revenue Market Share by Countries (2013-2018) Figure 2017 Asia Pacific Active Transdermal Drug Delivery Device Revenue Market Share by Countries Figure China Active Transdermal Drug Delivery Device Sales Growth Rate (2013-2018) (K Units) Figure China Active Transdermal Drug Delivery Device Revenue Growth Rate (2013-2018) (Million US$) Figure Japan Active Transdermal Drug Delivery Device Sales Growth Rate (2013-2018) (K Units) Figure Japan Active Transdermal Drug Delivery Device Revenue Growth Rate (2013-2018) (Million US$) Figure Korea Active Transdermal Drug Delivery Device Sales Growth Rate (2013-2018) (K Units) Figure Korea Active Transdermal Drug Delivery Device Revenue Growth Rate (2013-2018) (Million US$) Figure India Active Transdermal Drug Delivery Device Sales Growth Rate (2013-2018) (K Units) Figure India Active Transdermal Drug Delivery Device Revenue Growth Rate (2013-2018) (Million US$) Figure Australia Active Transdermal Drug Delivery Device Sales Growth Rate (2013-2018) (K Units) Figure Australia Active Transdermal Drug Delivery Device Revenue Growth Rate (2013-2018) (Million US$) Figure Indonesia Active Transdermal Drug Delivery Device Sales Growth Rate (2013-2018) (K Units) Figure Indonesia Active Transdermal Drug Delivery Device Revenue Growth Rate (2013-2018) (Million US$) Figure Malaysia Active Transdermal Drug Delivery Device Sales Growth Rate (2013-2018) (K Units) Figure Malaysia Active Transdermal Drug Delivery Device Revenue Growth Rate (2013-2018) (Million US$) Figure Philippines Active Transdermal Drug Delivery Device Sales Growth Rate (2013-2018) (K Units) Figure Philippines Active Transdermal Drug Delivery Device Revenue Growth Rate (2013-2018) (Million US$) Figure Thailand Active Transdermal Drug Delivery Device Sales Growth Rate (2013-2018) (K Units) Figure Thailand Active Transdermal Drug Delivery Device Revenue Growth Rate (2013-2018) (Million US$) Figure Vietnam Active Transdermal Drug Delivery Device Sales Growth Rate (2013-2018) (K Units) Figure Vietnam Active Transdermal Drug Delivery Device Revenue Growth Rate (2013-2018) (Million US$) Figure Singapore Active Transdermal Drug Delivery Device Sales Growth Rate (2013-2018) (K Units) Figure Singapore Active Transdermal Drug Delivery Device Revenue Growth Rate (2013-2018) (Million US$) Table Asia Pacific Active Transdermal Drug Delivery Device Sales by Product (2013-2018) (K Units) Table Asia Pacific Active Transdermal Drug Delivery Device Sales Market Share by Product (2013-2018) Figure 2017 Asia Pacific Active Transdermal Drug Delivery Device Market Share by Product Table Asia Pacific Active Transdermal Drug Delivery Device Sales by End User (2013-2018) (K Units) Table Asia Pacific Active Transdermal Drug Delivery Device Sales Market Share by End User (2013-2018) Figure 2017 Asia Pacific Active Transdermal Drug Delivery Device Market Share by End User Figure Central & South America Active Transdermal Drug Delivery Device Sales Growth Rate 2013-2018 (K Units) Figure Central & South America Active Transdermal Drug Delivery Device Revenue Growth Rate 2013-2018 (Million US$) Table Central & South America Active Transdermal Drug Delivery Device Sales by Countries (2013-2018) (K Units) Table Central & South America Active Transdermal Drug Delivery Device Sales Market Share by Countries (2013-2018) Figure 2017 Central & South America Active Transdermal Drug Delivery Device Sales Market Share by Countries Table Central & South America Active Transdermal Drug Delivery Device Revenue by Countries (2013-2018) (Million US$) Table Central & South America Active Transdermal Drug Delivery Device Revenue Market Share by Countries (2013-2018) Figure 2017 Central & South America Active Transdermal Drug Delivery Device Revenue Market Share by Countries Figure Brazil Active Transdermal Drug Delivery Device Sales Growth Rate (2013-2018) (K Units) Figure Brazil Active Transdermal Drug Delivery Device Revenue Growth Rate (2013-2018) (Million US$) Figure Argentina Active Transdermal Drug Delivery Device Sales Growth Rate (2013-2018) (K Units) Figure Argentina Active Transdermal Drug Delivery Device Revenue Growth Rate (2013-2018) (Million US$) Table Central & South America Active Transdermal Drug Delivery Device Sales by Product (2013-2018) (K Units) Table Central & South America Active Transdermal Drug Delivery Device Sales Market Share by Product (2013-2018) Figure 2017 Central & South America Active Transdermal Drug Delivery Device Market Share by Product Table Central & South America Active Transdermal Drug Delivery Device Sales by End User (2013-2018) (K Units) Table Central & South America Active Transdermal Drug Delivery Device Sales Market Share by End User (2013-2018) Figure 2017 Central & South America Active Transdermal Drug Delivery Device Market Share by End User Figure Middle East and Africa Active Transdermal Drug Delivery Device Sales Growth Rate 2013-2018 (K Units) Figure Middle East and Africa Active Transdermal Drug Delivery Device Revenue Growth Rate 2013-2018 (Million US$) Table Middle East and Africa Active Transdermal Drug Delivery Device Sales by Countries (2013-2018) (K Units) Table Middle East and Africa Active Transdermal Drug Delivery Device Sales Market Share by Countries (2013-2018) Figure 2017 Middle East and Africa Active Transdermal Drug Delivery Device Sales Market Share by Countries Table Middle East and Africa Active Transdermal Drug Delivery Device Revenue by Countries (2013-2018) (Million US$) Table Middle East and Africa Active Transdermal Drug Delivery Device Revenue Market Share by Countries (2013-2018) Figure 2017 Middle East and Africa Active Transdermal Drug Delivery Device Revenue Market Share by Countries Figure GCC Countries Active Transdermal Drug Delivery Device Sales Growth Rate (2013-2018) (K Units) Figure GCC Countries Active Transdermal Drug Delivery Device Revenue Growth Rate (2013-2018) (Million US$) Figure Turkey Active Transdermal Drug Delivery Device Sales Growth Rate (2013-2018) (K Units) Figure Turkey Active Transdermal Drug Delivery Device Revenue Growth Rate (2013-2018) (Million US$) Figure Egypt Active Transdermal Drug Delivery Device Sales Growth Rate (2013-2018) (K Units) Figure Egypt Active Transdermal Drug Delivery Device Revenue Growth Rate (2013-2018) (Million US$) Figure South Africa Active Transdermal Drug Delivery Device Sales Growth Rate (2013-2018) (K Units) Figure South Africa Active Transdermal Drug Delivery Device Revenue Growth Rate (2013-2018) (Million US$) Table Middle East and Africa Active Transdermal Drug Delivery Device Sales by Product (2013-2018) (K Units) Table Middle East and Africa Active Transdermal Drug Delivery Device Sales Market Share by Product (2013-2018) Figure 2017 Middle East and Africa Active Transdermal Drug Delivery Device Market Share by Product Table Middle East and Africa Active Transdermal Drug Delivery Device Sales by End User (2013-2018) (K Units) Table Middle East and Africa Active Transdermal Drug Delivery Device Sales Market Share by End User (2013-2018) Figure 2017 Middle East and Africa Active Transdermal Drug Delivery Device Market Share by End User Table Novartis AG Company Details Table Novartis AG Active Transdermal Drug Delivery Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Table Novartis AG Recent Development Table Noven Pharmaceuticals, Inc. Company Details Table Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Table Noven Pharmaceuticals, Inc. Recent Development Table Transdermal Corp. Company Details Table Transdermal Corp. Active Transdermal Drug Delivery Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Table Transdermal Corp. Recent Development Table Johnson & Johnson (Janssen Pharmaceuticals Inc.) Company Details Table Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Table Johnson & Johnson (Janssen Pharmaceuticals Inc.) Recent Development Table Mylan N.V. Company Details Table Mylan N.V. Active Transdermal Drug Delivery Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Table Mylan N.V. Recent Development Table 3M Company Details Table 3M Active Transdermal Drug Delivery Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Table 3M Recent Development Table Actavis, Inc. Company Details Table Actavis, Inc. Active Transdermal Drug Delivery Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Table Actavis, Inc. Recent Development Table Bayer AG Company Details Table Bayer AG Active Transdermal Drug Delivery Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Table Bayer AG Recent Development Table Boehringer Ingelheim GmbH Company Details Table Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Table Boehringer Ingelheim GmbH Recent Development Table Corium International, Inc. Company Details Table Corium International, Inc. Active Transdermal Drug Delivery Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Table Corium International, Inc. Recent Development Table Echo Therapeutics, Inc. Company Details Table GlaxoSmithKline plc Company Details Table Global Active Transdermal Drug Delivery Device Sales Forecast by Regions 2018-2025 (K Units) Table Global Active Transdermal Drug Delivery Device Sales Market Share Forecast by Regions 2018-2025 Table Global Active Transdermal Drug Delivery Device Revenue Forecast by Regions 2018-2025 (Million US$) Table Global Active Transdermal Drug Delivery Device Revenue Market Share Forecast by Regions 2018-2025 Table Global Active Transdermal Drug Delivery Device Sales Forecast by Product 2018-2025 (K Units) Table Global Active Transdermal Drug Delivery Device Sales Market Share Forecast by Product 2018-2025 Table Global Active Transdermal Drug Delivery Device Revenue Forecast by Product 2018-2025 (Million US$) Table Global Active Transdermal Drug Delivery Device Revenue Market Share Forecast by Product 2018-2025 Table Global Active Transdermal Drug Delivery Device Sales Forecast by End User 2018-2025 (K Units) Table Global Active Transdermal Drug Delivery Device Sales Market Share Forecast by End User 2018-2025 Figure North America Active Transdermal Drug Delivery Device Sales Growth Rate Forecast (2018-2025) (K Units) Figure North America Active Transdermal Drug Delivery Device Revenue Growth Rate Forecast (2018-2025) (Million US$) Figure Europe Active Transdermal Drug Delivery Device Sales Growth Rate Forecast (2018-2025) (K Units) Figure Europe Active Transdermal Drug Delivery Device Revenue Growth Rate Forecast (2018-2025) (Million US$) Figure Asia Pacific Active Transdermal Drug Delivery Device Sales Growth Rate Forecast (2018-2025) (K Units) Figure Asia Pacific Active Transdermal Drug Delivery Device Revenue Growth Rate Forecast (2018-2025) (Million US$) Figure Central & South America Active Transdermal Drug Delivery Device Sales Growth Rate Forecast (2018-2025) (K Units) Figure Central & South America Active Transdermal Drug Delivery Device Revenue Growth Rate Forecast (2018-2025) (Million US$) Figure Middle East and Africa Active Transdermal Drug Delivery Device Sales Growth Rate Forecast (2018-2025) (K Units) Figure Middle East and Africa Active Transdermal Drug Delivery Device Revenue Growth Rate Forecast (2018-2025) (Million US$) Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016 Figure Forecast of Global Middle-Class Population, 2015 to 2030 Figure Household Disposable Income Gross adjusted, US dollars/capita, 2016 Table Active Transdermal Drug Delivery Device Value Chain Table Active Transdermal Drug Delivery Device Customers List Table Active Transdermal Drug Delivery Device Distributors List Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Other Reports by QY Research

Global In Vivo Imaging System Microscopes Market Research Report 2018

This report studies the global In Vivo Imaging System Microscopes market status and forecast, categorizes the global In Vivo Imaging System Microscopes market size (value & volume) by manufacturers, type, application, and region. This report focuses ...

Global Microscopy Imaging System Market Research Report 2018

This report studies the global Microscopy Imaging System market status and forecast, categorizes the global Microscopy Imaging System market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufac...

Global Migration Inhibitors Market Research Report 2018

This report studies the global Migration Inhibitors market status and forecast, categorizes the global Migration Inhibitors market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in ...

Global Anti Migrating Agents Market Research Report 2018

This report studies the global Anti Migrating Agents market status and forecast, categorizes the global Anti Migrating Agents market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers i...

Global Running Shoes Market Research Report 2018

This report studies the global Running Shoes market status and forecast, categorizes the global Running Shoes market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America,...

New Medical Devices Reports